Does neutrophil-to-lymphocyte ratio predict active XXXX ?

@entity1 @entity32 @entity5 @entity31 @entity453 @entity1851
BACKGROUND: Inflammatory markers have been studied in @entity31 ( @entity31 ) for diagnosis, disease activity, and prediction of relapse. Blood neutrophil-to-lymphocyte (N/L) ratio has been used to determine outcomes of some @entity5 and @entity453 . Blood N/L ratio is a simple sign of clinical @entity32 . In this study, we examined N/L ratio in recurrent @entity1 suffering from @entity31 . METHODS: The aim of the present study was to analyze N/L ratios in serum samples of @entity31 @entity1 in remission and active phases. @entity1 ' age, extend of the disease, disease duration, disease activity, drug, and other medical history were all noted for @entity1 . @entity1851 , erythrocyte sedimentation rate, and complete blood count were determined for @entity1 . RESULTS: Forty-nine @entity31 @entity1 were admitted into the present study. The blood N/L ratios were significantly increased in active phase compared with inactive @entity31 @entity1 (p  <  0.05). The cut-off value for N/L ratio for the detection of active @entity31 @entity1 was calculated as >=   2.3 using receiver operating characteristic analysis [sensitivity: 61.2  %, specificity: 66.7  %, AUC: 0.650 (0.540-0.760), p  =  0.01]. CONCLUSIONS: Present study shows that in @entity1 with @entity31 , the blood N/L ratio is associated with active disease. N/L ratio may be used as an activity parameter in @entity31 .
